Innovation & Devices
Voceryq Enters Care for Recurrent Respiratory Papillomatosis
The FDA has granted accelerated approval to plasmid DNA-based Voceryq for adults with HPV-associated recurrent respiratory papillomatosis, adding an option while confirmatory evidence is developed.
Dr. Abu Bakar · November 8, 2026 · 6 min